Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

Antiviral medication has emerged as an important tool in the prevention of HIV infection. In this randomized, controlled trial, an injectable long-acting agent, cabotegravir, was found to be superior to daily oral tenofovir disoproxil fumarate–emtricitabine in preventing incident HIV infection in ci...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2021-08, Vol.385 (7), p.595-608
Hauptverfasser: Landovitz, Raphael J, Donnell, Deborah, Clement, Meredith E, Hanscom, Brett, Cottle, Leslie, Coelho, Lara, Cabello, Robinson, Chariyalertsak, Suwat, Dunne, Eileen F, Frank, Ian, Gallardo-Cartagena, Jorge A, Gaur, Aditya H, Gonzales, Pedro, Tran, Ha V, Hinojosa, Juan C, Kallas, Esper G, Kelley, Colleen F, Losso, Marcelo H, Madruga, J. Valdez, Middelkoop, Keren, Phanuphak, Nittaya, Santos, Breno, Sued, Omar, Valencia Huamaní, Javier, Overton, Edgar T, Swaminathan, Shobha, del Rio, Carlos, Gulick, Roy M, Richardson, Paul, Sullivan, Philip, Piwowar-Manning, Estelle, Marzinke, Mark, Hendrix, Craig, Li, Maoji, Wang, Zhe, Marrazzo, Jeanne, Daar, Eric, Asmelash, Aida, Brown, Todd T, Anderson, Peter, Eshleman, Susan H, Bryan, Marcus, Blanchette, Cheryl, Lucas, Jonathan, Psaros, Christina, Safren, Steven, Sugarman, Jeremy, Scott, Hyman, Eron, Joseph J, Fields, Sheldon D, Sista, Nirupama D, Gomez-Feliciano, Kailazarid, Jennings, Andrea, Kofron, Ryan M, Holtz, Timothy H, Shin, Katherine, Rooney, James F, Smith, Kimberly Y, Spreen, William, Margolis, David, Rinehart, Alex, Adeyeye, Adeola, Cohen, Myron S, McCauley, Marybeth, Grinsztejn, Beatriz
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 608
container_issue 7
container_start_page 595
container_title The New England journal of medicine
container_volume 385
creator Landovitz, Raphael J
Donnell, Deborah
Clement, Meredith E
Hanscom, Brett
Cottle, Leslie
Coelho, Lara
Cabello, Robinson
Chariyalertsak, Suwat
Dunne, Eileen F
Frank, Ian
Gallardo-Cartagena, Jorge A
Gaur, Aditya H
Gonzales, Pedro
Tran, Ha V
Hinojosa, Juan C
Kallas, Esper G
Kelley, Colleen F
Losso, Marcelo H
Madruga, J. Valdez
Middelkoop, Keren
Phanuphak, Nittaya
Santos, Breno
Sued, Omar
Valencia Huamaní, Javier
Overton, Edgar T
Swaminathan, Shobha
del Rio, Carlos
Gulick, Roy M
Richardson, Paul
Sullivan, Philip
Piwowar-Manning, Estelle
Marzinke, Mark
Hendrix, Craig
Li, Maoji
Wang, Zhe
Marrazzo, Jeanne
Daar, Eric
Asmelash, Aida
Brown, Todd T
Anderson, Peter
Eshleman, Susan H
Bryan, Marcus
Blanchette, Cheryl
Lucas, Jonathan
Psaros, Christina
Safren, Steven
Sugarman, Jeremy
Scott, Hyman
Eron, Joseph J
Fields, Sheldon D
Sista, Nirupama D
Gomez-Feliciano, Kailazarid
Jennings, Andrea
Kofron, Ryan M
Holtz, Timothy H
Shin, Katherine
Rooney, James F
Smith, Kimberly Y
Spreen, William
Margolis, David
Rinehart, Alex
Adeyeye, Adeola
Cohen, Myron S
McCauley, Marybeth
Grinsztejn, Beatriz
description Antiviral medication has emerged as an important tool in the prevention of HIV infection. In this randomized, controlled trial, an injectable long-acting agent, cabotegravir, was found to be superior to daily oral tenofovir disoproxil fumarate–emtricitabine in preventing incident HIV infection in cisgender men and transgender women who have sex with men.
doi_str_mv 10.1056/NEJMoa2101016
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2560829879</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2560829879</sourcerecordid><originalsourceid>FETCH-LOGICAL-m199t-ab3a496bb9994d6f25f46d0ed50d293534e25e7787a9e9d30bcc35618910a3e53</originalsourceid><addsrcrecordid>eNpdkE1Lw0AQhhdRbK0evUpABC_R_U72KKG1lVY9VD0um-6kpHQ3dZMU_PdG2x505jDw8jDMPAhdEnxHsJD3z8OnWWUowV3LI9QngrGYcyyPUR9jmsY8UayHzup6hbsiXJ2iHuMsUYrSPhplJq8aWAazLUNUVCEaT96j1wBb8E1Z-aj0UVbWS_AWQjQDHxlvo3kw_pB9VA78OTopzLqGi_0coLfRcJ6N4-nL4yR7mMaOKNXEJmeGK5nnSiluZUFFwaXFYAW2VDHBOFABSZImRoGyDOeLBROSpIpgw0CwAbrd7d2E6rOFutGurBewXhsPVVtrKiROqUq7nwfo-h-6qtrgu-t-KUZZynFHXe2pNndg9SaUzoQvfTDUATc7wLlae1g5TbD-Ma__mGffGLZwpw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2560323840</pqid></control><display><type>article</type><title>Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>New England Journal of Medicine</source><creator>Landovitz, Raphael J ; Donnell, Deborah ; Clement, Meredith E ; Hanscom, Brett ; Cottle, Leslie ; Coelho, Lara ; Cabello, Robinson ; Chariyalertsak, Suwat ; Dunne, Eileen F ; Frank, Ian ; Gallardo-Cartagena, Jorge A ; Gaur, Aditya H ; Gonzales, Pedro ; Tran, Ha V ; Hinojosa, Juan C ; Kallas, Esper G ; Kelley, Colleen F ; Losso, Marcelo H ; Madruga, J. Valdez ; Middelkoop, Keren ; Phanuphak, Nittaya ; Santos, Breno ; Sued, Omar ; Valencia Huamaní, Javier ; Overton, Edgar T ; Swaminathan, Shobha ; del Rio, Carlos ; Gulick, Roy M ; Richardson, Paul ; Sullivan, Philip ; Piwowar-Manning, Estelle ; Marzinke, Mark ; Hendrix, Craig ; Li, Maoji ; Wang, Zhe ; Marrazzo, Jeanne ; Daar, Eric ; Asmelash, Aida ; Brown, Todd T ; Anderson, Peter ; Eshleman, Susan H ; Bryan, Marcus ; Blanchette, Cheryl ; Lucas, Jonathan ; Psaros, Christina ; Safren, Steven ; Sugarman, Jeremy ; Scott, Hyman ; Eron, Joseph J ; Fields, Sheldon D ; Sista, Nirupama D ; Gomez-Feliciano, Kailazarid ; Jennings, Andrea ; Kofron, Ryan M ; Holtz, Timothy H ; Shin, Katherine ; Rooney, James F ; Smith, Kimberly Y ; Spreen, William ; Margolis, David ; Rinehart, Alex ; Adeyeye, Adeola ; Cohen, Myron S ; McCauley, Marybeth ; Grinsztejn, Beatriz</creator><creatorcontrib>Landovitz, Raphael J ; Donnell, Deborah ; Clement, Meredith E ; Hanscom, Brett ; Cottle, Leslie ; Coelho, Lara ; Cabello, Robinson ; Chariyalertsak, Suwat ; Dunne, Eileen F ; Frank, Ian ; Gallardo-Cartagena, Jorge A ; Gaur, Aditya H ; Gonzales, Pedro ; Tran, Ha V ; Hinojosa, Juan C ; Kallas, Esper G ; Kelley, Colleen F ; Losso, Marcelo H ; Madruga, J. Valdez ; Middelkoop, Keren ; Phanuphak, Nittaya ; Santos, Breno ; Sued, Omar ; Valencia Huamaní, Javier ; Overton, Edgar T ; Swaminathan, Shobha ; del Rio, Carlos ; Gulick, Roy M ; Richardson, Paul ; Sullivan, Philip ; Piwowar-Manning, Estelle ; Marzinke, Mark ; Hendrix, Craig ; Li, Maoji ; Wang, Zhe ; Marrazzo, Jeanne ; Daar, Eric ; Asmelash, Aida ; Brown, Todd T ; Anderson, Peter ; Eshleman, Susan H ; Bryan, Marcus ; Blanchette, Cheryl ; Lucas, Jonathan ; Psaros, Christina ; Safren, Steven ; Sugarman, Jeremy ; Scott, Hyman ; Eron, Joseph J ; Fields, Sheldon D ; Sista, Nirupama D ; Gomez-Feliciano, Kailazarid ; Jennings, Andrea ; Kofron, Ryan M ; Holtz, Timothy H ; Shin, Katherine ; Rooney, James F ; Smith, Kimberly Y ; Spreen, William ; Margolis, David ; Rinehart, Alex ; Adeyeye, Adeola ; Cohen, Myron S ; McCauley, Marybeth ; Grinsztejn, Beatriz ; HPTN 083 Study Team</creatorcontrib><description>Antiviral medication has emerged as an important tool in the prevention of HIV infection. In this randomized, controlled trial, an injectable long-acting agent, cabotegravir, was found to be superior to daily oral tenofovir disoproxil fumarate–emtricitabine in preventing incident HIV infection in cisgender men and transgender women who have sex with men.</description><identifier>ISSN: 0028-4793</identifier><identifier>ISSN: 1533-4406</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMoa2101016</identifier><identifier>PMID: 34379922</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Acquired immune deficiency syndrome ; Administration, Oral ; Adult ; Aged ; AIDS ; Allergies ; Anti-HIV Agents - therapeutic use ; Antigens ; Antiretroviral drugs ; Cisgender ; Delayed-Action Preparations - administration &amp; dosage ; Disease prevention ; Dosage ; Double-Blind Method ; Double-blind studies ; Drug Administration Schedule ; Drug dosages ; Drug Resistance - genetics ; Emtricitabine ; Female ; Gays &amp; lesbians ; Global Health ; Hepatitis ; HIV ; HIV Infections - prevention &amp; control ; HIV Integrase Inhibitors - administration &amp; dosage ; HIV Integrase Inhibitors - adverse effects ; Homosexuality, Male ; Human immunodeficiency virus ; Humans ; Infections ; Infectious Disease ; Infectious diseases ; Injections, Intramuscular - adverse effects ; Integrase ; Intention to Treat Analysis ; Laboratories ; Male ; Medication Adherence ; Mens health ; Middle Aged ; Plasma ; Pre-Exposure Prophylaxis ; Prophylaxis ; Pyridones - administration &amp; dosage ; Pyridones - adverse effects ; Tenofovir ; Tenofovir - therapeutic use ; Transgender Persons ; Womens health ; Young Adult</subject><ispartof>The New England journal of medicine, 2021-08, Vol.385 (7), p.595-608</ispartof><rights>Copyright © 2021 Massachusetts Medical Society. All rights reserved.</rights><rights>Copyright © 2021 Massachusetts Medical Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-1431-8912 ; 0000-0002-6639-5231</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa2101016$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJMoa2101016$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,776,780,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34379922$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Landovitz, Raphael J</creatorcontrib><creatorcontrib>Donnell, Deborah</creatorcontrib><creatorcontrib>Clement, Meredith E</creatorcontrib><creatorcontrib>Hanscom, Brett</creatorcontrib><creatorcontrib>Cottle, Leslie</creatorcontrib><creatorcontrib>Coelho, Lara</creatorcontrib><creatorcontrib>Cabello, Robinson</creatorcontrib><creatorcontrib>Chariyalertsak, Suwat</creatorcontrib><creatorcontrib>Dunne, Eileen F</creatorcontrib><creatorcontrib>Frank, Ian</creatorcontrib><creatorcontrib>Gallardo-Cartagena, Jorge A</creatorcontrib><creatorcontrib>Gaur, Aditya H</creatorcontrib><creatorcontrib>Gonzales, Pedro</creatorcontrib><creatorcontrib>Tran, Ha V</creatorcontrib><creatorcontrib>Hinojosa, Juan C</creatorcontrib><creatorcontrib>Kallas, Esper G</creatorcontrib><creatorcontrib>Kelley, Colleen F</creatorcontrib><creatorcontrib>Losso, Marcelo H</creatorcontrib><creatorcontrib>Madruga, J. Valdez</creatorcontrib><creatorcontrib>Middelkoop, Keren</creatorcontrib><creatorcontrib>Phanuphak, Nittaya</creatorcontrib><creatorcontrib>Santos, Breno</creatorcontrib><creatorcontrib>Sued, Omar</creatorcontrib><creatorcontrib>Valencia Huamaní, Javier</creatorcontrib><creatorcontrib>Overton, Edgar T</creatorcontrib><creatorcontrib>Swaminathan, Shobha</creatorcontrib><creatorcontrib>del Rio, Carlos</creatorcontrib><creatorcontrib>Gulick, Roy M</creatorcontrib><creatorcontrib>Richardson, Paul</creatorcontrib><creatorcontrib>Sullivan, Philip</creatorcontrib><creatorcontrib>Piwowar-Manning, Estelle</creatorcontrib><creatorcontrib>Marzinke, Mark</creatorcontrib><creatorcontrib>Hendrix, Craig</creatorcontrib><creatorcontrib>Li, Maoji</creatorcontrib><creatorcontrib>Wang, Zhe</creatorcontrib><creatorcontrib>Marrazzo, Jeanne</creatorcontrib><creatorcontrib>Daar, Eric</creatorcontrib><creatorcontrib>Asmelash, Aida</creatorcontrib><creatorcontrib>Brown, Todd T</creatorcontrib><creatorcontrib>Anderson, Peter</creatorcontrib><creatorcontrib>Eshleman, Susan H</creatorcontrib><creatorcontrib>Bryan, Marcus</creatorcontrib><creatorcontrib>Blanchette, Cheryl</creatorcontrib><creatorcontrib>Lucas, Jonathan</creatorcontrib><creatorcontrib>Psaros, Christina</creatorcontrib><creatorcontrib>Safren, Steven</creatorcontrib><creatorcontrib>Sugarman, Jeremy</creatorcontrib><creatorcontrib>Scott, Hyman</creatorcontrib><creatorcontrib>Eron, Joseph J</creatorcontrib><creatorcontrib>Fields, Sheldon D</creatorcontrib><creatorcontrib>Sista, Nirupama D</creatorcontrib><creatorcontrib>Gomez-Feliciano, Kailazarid</creatorcontrib><creatorcontrib>Jennings, Andrea</creatorcontrib><creatorcontrib>Kofron, Ryan M</creatorcontrib><creatorcontrib>Holtz, Timothy H</creatorcontrib><creatorcontrib>Shin, Katherine</creatorcontrib><creatorcontrib>Rooney, James F</creatorcontrib><creatorcontrib>Smith, Kimberly Y</creatorcontrib><creatorcontrib>Spreen, William</creatorcontrib><creatorcontrib>Margolis, David</creatorcontrib><creatorcontrib>Rinehart, Alex</creatorcontrib><creatorcontrib>Adeyeye, Adeola</creatorcontrib><creatorcontrib>Cohen, Myron S</creatorcontrib><creatorcontrib>McCauley, Marybeth</creatorcontrib><creatorcontrib>Grinsztejn, Beatriz</creatorcontrib><creatorcontrib>HPTN 083 Study Team</creatorcontrib><title>Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Antiviral medication has emerged as an important tool in the prevention of HIV infection. In this randomized, controlled trial, an injectable long-acting agent, cabotegravir, was found to be superior to daily oral tenofovir disoproxil fumarate–emtricitabine in preventing incident HIV infection in cisgender men and transgender women who have sex with men.</description><subject>Acquired immune deficiency syndrome</subject><subject>Administration, Oral</subject><subject>Adult</subject><subject>Aged</subject><subject>AIDS</subject><subject>Allergies</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antigens</subject><subject>Antiretroviral drugs</subject><subject>Cisgender</subject><subject>Delayed-Action Preparations - administration &amp; dosage</subject><subject>Disease prevention</subject><subject>Dosage</subject><subject>Double-Blind Method</subject><subject>Double-blind studies</subject><subject>Drug Administration Schedule</subject><subject>Drug dosages</subject><subject>Drug Resistance - genetics</subject><subject>Emtricitabine</subject><subject>Female</subject><subject>Gays &amp; lesbians</subject><subject>Global Health</subject><subject>Hepatitis</subject><subject>HIV</subject><subject>HIV Infections - prevention &amp; control</subject><subject>HIV Integrase Inhibitors - administration &amp; dosage</subject><subject>HIV Integrase Inhibitors - adverse effects</subject><subject>Homosexuality, Male</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Injections, Intramuscular - adverse effects</subject><subject>Integrase</subject><subject>Intention to Treat Analysis</subject><subject>Laboratories</subject><subject>Male</subject><subject>Medication Adherence</subject><subject>Mens health</subject><subject>Middle Aged</subject><subject>Plasma</subject><subject>Pre-Exposure Prophylaxis</subject><subject>Prophylaxis</subject><subject>Pyridones - administration &amp; dosage</subject><subject>Pyridones - adverse effects</subject><subject>Tenofovir</subject><subject>Tenofovir - therapeutic use</subject><subject>Transgender Persons</subject><subject>Womens health</subject><subject>Young Adult</subject><issn>0028-4793</issn><issn>1533-4406</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkE1Lw0AQhhdRbK0evUpABC_R_U72KKG1lVY9VD0um-6kpHQ3dZMU_PdG2x505jDw8jDMPAhdEnxHsJD3z8OnWWUowV3LI9QngrGYcyyPUR9jmsY8UayHzup6hbsiXJ2iHuMsUYrSPhplJq8aWAazLUNUVCEaT96j1wBb8E1Z-aj0UVbWS_AWQjQDHxlvo3kw_pB9VA78OTopzLqGi_0coLfRcJ6N4-nL4yR7mMaOKNXEJmeGK5nnSiluZUFFwaXFYAW2VDHBOFABSZImRoGyDOeLBROSpIpgw0CwAbrd7d2E6rOFutGurBewXhsPVVtrKiROqUq7nwfo-h-6qtrgu-t-KUZZynFHXe2pNndg9SaUzoQvfTDUATc7wLlae1g5TbD-Ma__mGffGLZwpw</recordid><startdate>20210812</startdate><enddate>20210812</enddate><creator>Landovitz, Raphael J</creator><creator>Donnell, Deborah</creator><creator>Clement, Meredith E</creator><creator>Hanscom, Brett</creator><creator>Cottle, Leslie</creator><creator>Coelho, Lara</creator><creator>Cabello, Robinson</creator><creator>Chariyalertsak, Suwat</creator><creator>Dunne, Eileen F</creator><creator>Frank, Ian</creator><creator>Gallardo-Cartagena, Jorge A</creator><creator>Gaur, Aditya H</creator><creator>Gonzales, Pedro</creator><creator>Tran, Ha V</creator><creator>Hinojosa, Juan C</creator><creator>Kallas, Esper G</creator><creator>Kelley, Colleen F</creator><creator>Losso, Marcelo H</creator><creator>Madruga, J. Valdez</creator><creator>Middelkoop, Keren</creator><creator>Phanuphak, Nittaya</creator><creator>Santos, Breno</creator><creator>Sued, Omar</creator><creator>Valencia Huamaní, Javier</creator><creator>Overton, Edgar T</creator><creator>Swaminathan, Shobha</creator><creator>del Rio, Carlos</creator><creator>Gulick, Roy M</creator><creator>Richardson, Paul</creator><creator>Sullivan, Philip</creator><creator>Piwowar-Manning, Estelle</creator><creator>Marzinke, Mark</creator><creator>Hendrix, Craig</creator><creator>Li, Maoji</creator><creator>Wang, Zhe</creator><creator>Marrazzo, Jeanne</creator><creator>Daar, Eric</creator><creator>Asmelash, Aida</creator><creator>Brown, Todd T</creator><creator>Anderson, Peter</creator><creator>Eshleman, Susan H</creator><creator>Bryan, Marcus</creator><creator>Blanchette, Cheryl</creator><creator>Lucas, Jonathan</creator><creator>Psaros, Christina</creator><creator>Safren, Steven</creator><creator>Sugarman, Jeremy</creator><creator>Scott, Hyman</creator><creator>Eron, Joseph J</creator><creator>Fields, Sheldon D</creator><creator>Sista, Nirupama D</creator><creator>Gomez-Feliciano, Kailazarid</creator><creator>Jennings, Andrea</creator><creator>Kofron, Ryan M</creator><creator>Holtz, Timothy H</creator><creator>Shin, Katherine</creator><creator>Rooney, James F</creator><creator>Smith, Kimberly Y</creator><creator>Spreen, William</creator><creator>Margolis, David</creator><creator>Rinehart, Alex</creator><creator>Adeyeye, Adeola</creator><creator>Cohen, Myron S</creator><creator>McCauley, Marybeth</creator><creator>Grinsztejn, Beatriz</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1431-8912</orcidid><orcidid>https://orcid.org/0000-0002-6639-5231</orcidid></search><sort><creationdate>20210812</creationdate><title>Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women</title><author>Landovitz, Raphael J ; Donnell, Deborah ; Clement, Meredith E ; Hanscom, Brett ; Cottle, Leslie ; Coelho, Lara ; Cabello, Robinson ; Chariyalertsak, Suwat ; Dunne, Eileen F ; Frank, Ian ; Gallardo-Cartagena, Jorge A ; Gaur, Aditya H ; Gonzales, Pedro ; Tran, Ha V ; Hinojosa, Juan C ; Kallas, Esper G ; Kelley, Colleen F ; Losso, Marcelo H ; Madruga, J. Valdez ; Middelkoop, Keren ; Phanuphak, Nittaya ; Santos, Breno ; Sued, Omar ; Valencia Huamaní, Javier ; Overton, Edgar T ; Swaminathan, Shobha ; del Rio, Carlos ; Gulick, Roy M ; Richardson, Paul ; Sullivan, Philip ; Piwowar-Manning, Estelle ; Marzinke, Mark ; Hendrix, Craig ; Li, Maoji ; Wang, Zhe ; Marrazzo, Jeanne ; Daar, Eric ; Asmelash, Aida ; Brown, Todd T ; Anderson, Peter ; Eshleman, Susan H ; Bryan, Marcus ; Blanchette, Cheryl ; Lucas, Jonathan ; Psaros, Christina ; Safren, Steven ; Sugarman, Jeremy ; Scott, Hyman ; Eron, Joseph J ; Fields, Sheldon D ; Sista, Nirupama D ; Gomez-Feliciano, Kailazarid ; Jennings, Andrea ; Kofron, Ryan M ; Holtz, Timothy H ; Shin, Katherine ; Rooney, James F ; Smith, Kimberly Y ; Spreen, William ; Margolis, David ; Rinehart, Alex ; Adeyeye, Adeola ; Cohen, Myron S ; McCauley, Marybeth ; Grinsztejn, Beatriz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-m199t-ab3a496bb9994d6f25f46d0ed50d293534e25e7787a9e9d30bcc35618910a3e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Administration, Oral</topic><topic>Adult</topic><topic>Aged</topic><topic>AIDS</topic><topic>Allergies</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antigens</topic><topic>Antiretroviral drugs</topic><topic>Cisgender</topic><topic>Delayed-Action Preparations - administration &amp; dosage</topic><topic>Disease prevention</topic><topic>Dosage</topic><topic>Double-Blind Method</topic><topic>Double-blind studies</topic><topic>Drug Administration Schedule</topic><topic>Drug dosages</topic><topic>Drug Resistance - genetics</topic><topic>Emtricitabine</topic><topic>Female</topic><topic>Gays &amp; lesbians</topic><topic>Global Health</topic><topic>Hepatitis</topic><topic>HIV</topic><topic>HIV Infections - prevention &amp; control</topic><topic>HIV Integrase Inhibitors - administration &amp; dosage</topic><topic>HIV Integrase Inhibitors - adverse effects</topic><topic>Homosexuality, Male</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Injections, Intramuscular - adverse effects</topic><topic>Integrase</topic><topic>Intention to Treat Analysis</topic><topic>Laboratories</topic><topic>Male</topic><topic>Medication Adherence</topic><topic>Mens health</topic><topic>Middle Aged</topic><topic>Plasma</topic><topic>Pre-Exposure Prophylaxis</topic><topic>Prophylaxis</topic><topic>Pyridones - administration &amp; dosage</topic><topic>Pyridones - adverse effects</topic><topic>Tenofovir</topic><topic>Tenofovir - therapeutic use</topic><topic>Transgender Persons</topic><topic>Womens health</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Landovitz, Raphael J</creatorcontrib><creatorcontrib>Donnell, Deborah</creatorcontrib><creatorcontrib>Clement, Meredith E</creatorcontrib><creatorcontrib>Hanscom, Brett</creatorcontrib><creatorcontrib>Cottle, Leslie</creatorcontrib><creatorcontrib>Coelho, Lara</creatorcontrib><creatorcontrib>Cabello, Robinson</creatorcontrib><creatorcontrib>Chariyalertsak, Suwat</creatorcontrib><creatorcontrib>Dunne, Eileen F</creatorcontrib><creatorcontrib>Frank, Ian</creatorcontrib><creatorcontrib>Gallardo-Cartagena, Jorge A</creatorcontrib><creatorcontrib>Gaur, Aditya H</creatorcontrib><creatorcontrib>Gonzales, Pedro</creatorcontrib><creatorcontrib>Tran, Ha V</creatorcontrib><creatorcontrib>Hinojosa, Juan C</creatorcontrib><creatorcontrib>Kallas, Esper G</creatorcontrib><creatorcontrib>Kelley, Colleen F</creatorcontrib><creatorcontrib>Losso, Marcelo H</creatorcontrib><creatorcontrib>Madruga, J. Valdez</creatorcontrib><creatorcontrib>Middelkoop, Keren</creatorcontrib><creatorcontrib>Phanuphak, Nittaya</creatorcontrib><creatorcontrib>Santos, Breno</creatorcontrib><creatorcontrib>Sued, Omar</creatorcontrib><creatorcontrib>Valencia Huamaní, Javier</creatorcontrib><creatorcontrib>Overton, Edgar T</creatorcontrib><creatorcontrib>Swaminathan, Shobha</creatorcontrib><creatorcontrib>del Rio, Carlos</creatorcontrib><creatorcontrib>Gulick, Roy M</creatorcontrib><creatorcontrib>Richardson, Paul</creatorcontrib><creatorcontrib>Sullivan, Philip</creatorcontrib><creatorcontrib>Piwowar-Manning, Estelle</creatorcontrib><creatorcontrib>Marzinke, Mark</creatorcontrib><creatorcontrib>Hendrix, Craig</creatorcontrib><creatorcontrib>Li, Maoji</creatorcontrib><creatorcontrib>Wang, Zhe</creatorcontrib><creatorcontrib>Marrazzo, Jeanne</creatorcontrib><creatorcontrib>Daar, Eric</creatorcontrib><creatorcontrib>Asmelash, Aida</creatorcontrib><creatorcontrib>Brown, Todd T</creatorcontrib><creatorcontrib>Anderson, Peter</creatorcontrib><creatorcontrib>Eshleman, Susan H</creatorcontrib><creatorcontrib>Bryan, Marcus</creatorcontrib><creatorcontrib>Blanchette, Cheryl</creatorcontrib><creatorcontrib>Lucas, Jonathan</creatorcontrib><creatorcontrib>Psaros, Christina</creatorcontrib><creatorcontrib>Safren, Steven</creatorcontrib><creatorcontrib>Sugarman, Jeremy</creatorcontrib><creatorcontrib>Scott, Hyman</creatorcontrib><creatorcontrib>Eron, Joseph J</creatorcontrib><creatorcontrib>Fields, Sheldon D</creatorcontrib><creatorcontrib>Sista, Nirupama D</creatorcontrib><creatorcontrib>Gomez-Feliciano, Kailazarid</creatorcontrib><creatorcontrib>Jennings, Andrea</creatorcontrib><creatorcontrib>Kofron, Ryan M</creatorcontrib><creatorcontrib>Holtz, Timothy H</creatorcontrib><creatorcontrib>Shin, Katherine</creatorcontrib><creatorcontrib>Rooney, James F</creatorcontrib><creatorcontrib>Smith, Kimberly Y</creatorcontrib><creatorcontrib>Spreen, William</creatorcontrib><creatorcontrib>Margolis, David</creatorcontrib><creatorcontrib>Rinehart, Alex</creatorcontrib><creatorcontrib>Adeyeye, Adeola</creatorcontrib><creatorcontrib>Cohen, Myron S</creatorcontrib><creatorcontrib>McCauley, Marybeth</creatorcontrib><creatorcontrib>Grinsztejn, Beatriz</creatorcontrib><creatorcontrib>HPTN 083 Study Team</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Landovitz, Raphael J</au><au>Donnell, Deborah</au><au>Clement, Meredith E</au><au>Hanscom, Brett</au><au>Cottle, Leslie</au><au>Coelho, Lara</au><au>Cabello, Robinson</au><au>Chariyalertsak, Suwat</au><au>Dunne, Eileen F</au><au>Frank, Ian</au><au>Gallardo-Cartagena, Jorge A</au><au>Gaur, Aditya H</au><au>Gonzales, Pedro</au><au>Tran, Ha V</au><au>Hinojosa, Juan C</au><au>Kallas, Esper G</au><au>Kelley, Colleen F</au><au>Losso, Marcelo H</au><au>Madruga, J. Valdez</au><au>Middelkoop, Keren</au><au>Phanuphak, Nittaya</au><au>Santos, Breno</au><au>Sued, Omar</au><au>Valencia Huamaní, Javier</au><au>Overton, Edgar T</au><au>Swaminathan, Shobha</au><au>del Rio, Carlos</au><au>Gulick, Roy M</au><au>Richardson, Paul</au><au>Sullivan, Philip</au><au>Piwowar-Manning, Estelle</au><au>Marzinke, Mark</au><au>Hendrix, Craig</au><au>Li, Maoji</au><au>Wang, Zhe</au><au>Marrazzo, Jeanne</au><au>Daar, Eric</au><au>Asmelash, Aida</au><au>Brown, Todd T</au><au>Anderson, Peter</au><au>Eshleman, Susan H</au><au>Bryan, Marcus</au><au>Blanchette, Cheryl</au><au>Lucas, Jonathan</au><au>Psaros, Christina</au><au>Safren, Steven</au><au>Sugarman, Jeremy</au><au>Scott, Hyman</au><au>Eron, Joseph J</au><au>Fields, Sheldon D</au><au>Sista, Nirupama D</au><au>Gomez-Feliciano, Kailazarid</au><au>Jennings, Andrea</au><au>Kofron, Ryan M</au><au>Holtz, Timothy H</au><au>Shin, Katherine</au><au>Rooney, James F</au><au>Smith, Kimberly Y</au><au>Spreen, William</au><au>Margolis, David</au><au>Rinehart, Alex</au><au>Adeyeye, Adeola</au><au>Cohen, Myron S</au><au>McCauley, Marybeth</au><au>Grinsztejn, Beatriz</au><aucorp>HPTN 083 Study Team</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2021-08-12</date><risdate>2021</risdate><volume>385</volume><issue>7</issue><spage>595</spage><epage>608</epage><pages>595-608</pages><issn>0028-4793</issn><issn>1533-4406</issn><eissn>1533-4406</eissn><abstract>Antiviral medication has emerged as an important tool in the prevention of HIV infection. In this randomized, controlled trial, an injectable long-acting agent, cabotegravir, was found to be superior to daily oral tenofovir disoproxil fumarate–emtricitabine in preventing incident HIV infection in cisgender men and transgender women who have sex with men.</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>34379922</pmid><doi>10.1056/NEJMoa2101016</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-1431-8912</orcidid><orcidid>https://orcid.org/0000-0002-6639-5231</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 2021-08, Vol.385 (7), p.595-608
issn 0028-4793
1533-4406
1533-4406
language eng
recordid cdi_proquest_miscellaneous_2560829879
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; New England Journal of Medicine
subjects Acquired immune deficiency syndrome
Administration, Oral
Adult
Aged
AIDS
Allergies
Anti-HIV Agents - therapeutic use
Antigens
Antiretroviral drugs
Cisgender
Delayed-Action Preparations - administration & dosage
Disease prevention
Dosage
Double-Blind Method
Double-blind studies
Drug Administration Schedule
Drug dosages
Drug Resistance - genetics
Emtricitabine
Female
Gays & lesbians
Global Health
Hepatitis
HIV
HIV Infections - prevention & control
HIV Integrase Inhibitors - administration & dosage
HIV Integrase Inhibitors - adverse effects
Homosexuality, Male
Human immunodeficiency virus
Humans
Infections
Infectious Disease
Infectious diseases
Injections, Intramuscular - adverse effects
Integrase
Intention to Treat Analysis
Laboratories
Male
Medication Adherence
Mens health
Middle Aged
Plasma
Pre-Exposure Prophylaxis
Prophylaxis
Pyridones - administration & dosage
Pyridones - adverse effects
Tenofovir
Tenofovir - therapeutic use
Transgender Persons
Womens health
Young Adult
title Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T22%3A59%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cabotegravir%20for%20HIV%20Prevention%20in%20Cisgender%20Men%20and%20Transgender%20Women&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Landovitz,%20Raphael%20J&rft.aucorp=HPTN%20083%20Study%20Team&rft.date=2021-08-12&rft.volume=385&rft.issue=7&rft.spage=595&rft.epage=608&rft.pages=595-608&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMoa2101016&rft_dat=%3Cproquest_pubme%3E2560829879%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2560323840&rft_id=info:pmid/34379922&rfr_iscdi=true